Accord Healthcare, Inc. recalls Levothyroxine Sodium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug
- Products
-
- Levothyroxine Sodium Tablets
- Company
- Accord Healthcare, Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- N/A
- About this recall
- Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.